| __timestamp | Biogen Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1893422000 | 79838000 |
| Thursday, January 1, 2015 | 2012800000 | 121816000 |
| Friday, January 1, 2016 | 1973300000 | 117633000 |
| Sunday, January 1, 2017 | 2253600000 | 117456000 |
| Monday, January 1, 2018 | 2597200000 | 171984000 |
| Tuesday, January 1, 2019 | 2280600000 | 257452000 |
| Wednesday, January 1, 2020 | 3990900000 | 477643000 |
| Friday, January 1, 2021 | 2501200000 | 540684000 |
| Saturday, January 1, 2022 | 2231100000 | 651496000 |
| Sunday, January 1, 2023 | 2702600000 | 666563000 |
| Monday, January 1, 2024 | 2041800000 |
Unlocking the unknown
In the competitive world of biotechnology, innovation is key to staying ahead. Biogen Inc. and PTC Therapeutics, Inc. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Biogen consistently outspent PTC Therapeutics, with R&D expenses peaking in 2020 at nearly double their 2014 levels. This surge reflects Biogen's commitment to pioneering new treatments and therapies. Meanwhile, PTC Therapeutics has shown a remarkable growth trajectory, increasing its R&D spending by over 700% during the same period. This rapid increase underscores PTC's aggressive push to innovate and expand its portfolio. As the biotech landscape evolves, these investments highlight the strategic priorities of each company, with Biogen focusing on sustained innovation and PTC Therapeutics on rapid growth.
Comparing Innovation Spending: Novartis AG and PTC Therapeutics, Inc.
Research and Development Investment: Zoetis Inc. vs PTC Therapeutics, Inc.
Research and Development Expenses Breakdown: Biogen Inc. vs Sarepta Therapeutics, Inc.
Research and Development Investment: Biogen Inc. vs Axsome Therapeutics, Inc.
Research and Development Investment: Biogen Inc. vs Lantheus Holdings, Inc.
R&D Insights: How Biogen Inc. and Evotec SE Allocate Funds
United Therapeutics Corporation or PTC Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and PTC Therapeutics, Inc.
PTC Therapeutics, Inc. vs Veracyte, Inc.: Strategic Focus on R&D Spending
PTC Therapeutics, Inc. vs MorphoSys AG: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for PTC Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd.
Research and Development Expenses Breakdown: PTC Therapeutics, Inc. vs Evotec SE